日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Real-World Outcomes of Sequential Afatinib and Osimertinib Versus Afatinib and Chemotherapy in EGFR-Mutant NSCLC: Taiwan Multicenter GIANT Study

EGFR突变型非小细胞肺癌患者序贯阿法替尼联合奥希替尼与阿法替尼联合化疗的真实世界疗效:台湾多中心GIANT研究

Ko, How-Wen; Liao, Ying-Ting; Liang, Sheng-Kai; Huang, Yen-Hsiang; Lin, Yu-Ching; Liu, Ping-Chi; Wang, Chin-Chou; Tsai, Jeng-Shiuan; Chen, Yuh-Min; Shih, Jin-Yuan; Yang, Tsung-Ying; Yang, Chang-Ta

Vitamin B1 Involved in Dendrobium Taiseed Tosnobile Extract Mediates Protection Against Cancer-Induced Muscle Wasting by Suppressing IL-6 Pathogenicity and Enhancing Myoblast Fusion.

维生素 B1 参与了石斛提取物,通过抑制 IL-6 致病性和增强成肌细胞融合来介导对癌症引起的肌肉萎缩的保护作用。

Lin Chen-Chu, Liao Wan-Ting, Yang Tsung-Ying, Tsai Jing-Hua, Lee Yi-Ju, Wen Chi-Luan, Hsu Shih-Lan, Wu Chun-Chi

In Silico Design of Antimicrobial Peptides against Carbapenem-Resistant Acinetobacter baumannii Infections with Enhanced Activity by Nanoformulation

利用纳米制剂增强抗菌肽对耐碳青霉烯类鲍曼不动杆菌感染的活性,并通过计算机辅助设计实现

Richardson, Lawrance; Yang, Tsung-Ying; Chen, Yu-Wei; Lin, Shang-Yi; Wang, Yeng-Tseng; Lu, Po-Liang; Chan, Yang-Hsiang; Lin, Hong-Cheu

Durvalumab, Tremelimumab, and Platinum Chemotherapy in EGFR Mutation-Positive NSCLC: An Open-Label Phase 2 Trial (ILLUMINATE)

Durvalumab、Tremelimumab 和铂类化疗治疗 EGFR 突变阳性非小细胞肺癌:一项开放标签 2 期试验 (ILLUMINATE)

Lee, Chee Khoon; Liao, Bin-Chi; Subramaniam, Shalini; Chiu, Chao-Hua; Mersiades, Antony J; Ho, Chao-Chi; Brown, Chris; Lai, Chun-Liang; Hughes, Brett G M; Yang, Tsung-Ying; O'Byrne, Ken; Luo, Yung-Hung; Yip, Sonia; Ho, Ching-Liang; Bray, Victoria; Su, Wu-Chou; Moore, Melissa; Feng, Wei-Lien; Bai, Ya-Ying; Ford, Kate; Cummins, Michelle M; Stockler, Martin R; Solomon, Benjamin J; John, Thomas; Chih-Hsin Yang, James

Evaluation of thermal desorption-electrospray ionization mass spectrometry for characterization of Mycobacterium tuberculosis: Comparison with MIRU-VNTR and whole-genome sequencing

评估热脱附-电喷雾电离质谱法在结核分枝杆菌鉴定中的应用:与MIRU-VNTR和全基因组测序的比较

Yang, Tsung-Ying; Su, Hung; Jain, Shu-Huei; Lin, Hsien-Ho; Wu, Chieh-Yin; Chen, Chao-Ju; Shiea, Jentaie; Lu, Po-Liang

Antimicrobial properties of bimetallic-containing mesoporous bioglass against Enterococcus faecalis

含双金属介孔生物玻璃对粪肠球菌的抗菌性能

Wong, Kin-Weng; Li, Yi-Ju; Yang, Hui-Ci; Chien, Chi-Sheng; Kao, Li-Ting; Lin, Ting-Sheng; Yang, Tsung-Ying; Shih, Chi-Jen

Survival Outcomes in Lung Cancer Patients Newly Diagnosed Through Brain Metastasis Surgery: Impact of Druggable Mutations and Radiotherapy

通过脑转移手术新诊断的肺癌患者的生存结局:可药物靶向突变和放射治疗的影响

Chuang, Tzu-I; Hsu, Kuo-Hsuan; Lee, Po-Hsin; Tseng, Jeng-Sen; Hsu, Yu-Wei; Liao, Chih-Hsiang; Huang, Yen-Hsiang; Yang, Tsung-Ying

Real-world treatment patterns and subsequent treatment effectiveness following frontline brigatinib in the ALTA-1L trial

ALTA-1L试验中一线布加替尼治疗后的真实世界治疗模式和后续治疗效果

Ahn, Myung-Ju; Delmonte, Angelo; Ghosh, Sharmistha; Hochmair, Maximilian; Yang, Tsung-Ying; Yang, James Chih-Hsin; Han, Ji-Youn; Hansen, Karin Holmskov; Wu, Yanyu; Wan, Yin; Lin, Huamao Mark; Kretz, Julian; Hupf, Bradley; Kurec, Ahmet Melih; Churchill, Eric N; Fram, Robert J; Cabasag, Citadel Jungco; Goriya, Vishal; Zhao, Yuzhe; Campelo, Maria Rosario García

A plain language summary of results from the FLAURA2 study: Effects of initial (first-line) osimertinib plus chemotherapy on the brain in patients with EGFR-mutated advanced non-small cell lung cancer

FLAURA2 研究结果的简明语言摘要:一线奥希替尼联合化疗对 EGFR 突变晚期非小细胞肺癌患者脑部的影响

Jänne, Pasi A; Planchard, David; Kobayashi, Kunihiko; Cheng, Ying; Lee, Chee Khoon; Valdiviezo, Natalia; Laktionov, Konstantin; Yang, Tsung-Ying; Yu, Yan; Kato, Terufumi; Jiang, Liyan; Chewaskulyong, Busyamas; Geater, Sarayut Lucien; Maurel, Jean-Marc; Rojas, Carlos; Takahashi, Toshiaki; Shepherd, Frances A; Tanaka, Kentaro; Ghiorghiu, Dana; Amin, Neha P; Armenteros-Monterroso, Elena; Huang, Xiangning; Ahmed Chaudhry, Ammar; Yang, James Chih-Hsin

Real-world therapeutic strategies and survival outcomes in advanced HER2 -mutant non-small cell lung cancer

晚期 HER2 突变型非小细胞肺癌的真实世界治疗策略和生存结果

Sun, Ruei-Lin; Liao, Pei-Ya; Liao, Ying-Ting; Yeh, Yi-Chen; Chiang, Chi-Lu; Chen, Yuh-Min; Hsu, Kuo-Hsuan; Tseng, Jeng-Sen; Huang, Hsu-Ching; Shen, Chia-I; Tseng, Yen-Han; Huang, Yen-Hsiang; Luo, Yung-Hung; Yang, Tsung-Ying